Loading company…
Synthesize Bio uses generative AI to predict gene expression and support drug development.
Synthesize Bio develops generative AI models that predict gene expression outcomes and support biomarker-driven trials, precision medicine and drug research. Its Generative Genomics Engine combines multi-omics data with public biological knowledge. Founded in 2023 in Seattle, the company raised USD 10.00 mn in Seed funding on September 16, 2025, led by Madrona Venture Group with AI2 Incubator and Inner Loop Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in